NCT04652648View on ClinicalTrials.gov

Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

November 15, 2020

Conditions
Covid19HydroxychloroquineCoronavirus InfectionTransmissionProphylaxis
Interventions
DRUG

Hydroxychloroquine

Randomization was 2:1 to HCQ 200 mg BID or 41 observation for 10 days

Trial Locations (3)

19010

Bryn Mawr Hospital, Bryn Mawr

19096

Lankenau Medical Center, Wynnewood

19301

Paoli Hospital, Paoli

All Listed Sponsors
collaborator

Sharpe-Strumia Research Foundation

OTHER

collaborator

Bryn Mawr Hospital Foundation

UNKNOWN

collaborator

Cotswold Foundation

UNKNOWN

lead

Bryn Mawr Hospital

OTHER

NCT04652648 - Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts | Biotech Hunter | Biotech Hunter